Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round. This story matters for AI & Agent Economy readers tracking net. Reported by techcrunch.com. Read the full original at the source link below.
Originally reported by techcrunch.com. NetNewsletter.com curates and briefs the ai & agent economy stories that matter. Our editorial policy →
Get the daily net signal